12.27.12
A new study published in theJournal of Pediatric Gastroenterology and Nutrition, demonstrates for the first time that InFat (Advanced Lipids, a joint venture between AAK and Enzymotec(, a high beta-palmitate fat blend, provides beneficial effects for the health and well-being of formula-fed infants. This double-blind, randomized, multicenter study shows a significant increase in Lactobacilli and Bifidobacteria abundance in the microbiota, shifting the flora composition to be more comparable to breastfed infants. The clinical trialincluded 36 term infants,14 breast-fed and 22 formula-fed who were randomly assigned to receive either formula with InFat (high beta-palmitate) or a control formula (standard vegetable oil mix) that did not contain any pre- or probiotics. Stool samples were collected at enrollment and at six weeks postnatal for the quantification of different bacteria constituting the gut flora. The trial’s results indicate that InFat can improve infant formula, making it closer to human breast milk in terms of the infants’ flora composition.
For further information: www.enzymotec.com
For further information: www.enzymotec.com